Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 1
This study looked at a cancer growth blocker called buparlisib and radiotherapy for a type of lung cancer called non small cell lung cancer. It was supported by Cancer Research UK.
Recruitment start: 18 April 2013
Recruitment end: 31 August 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Geoff Higgins
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Oxford Cancer Imaging Centre
University of Oxford
This is Cancer Research UK trial number CRUKD/12/016.
Last reviewed: 28 Apr 2019
CRUK internal database number: 9955